Fluxion Inks Deal with German Distributor | GenomeWeb
NEW YORK (GenomeWeb News) – Fluxion today said that IUL Instruments will handle sales and service of the firm’s BioFlux research tools for live cell image analysis in drug discovery in Germany and Austria, under an exclusive distribution deal.
 
Königswinter, Germany-based IUL specializes in selling instruments for microbiology, cell biology, and biotech applications, said Fluxion. IUL’s efforts will mark Fluxion’s entry into the German and Austrian markets.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.